Presentation THT 2023 Intranasal Diuretic for the Treatment of CHF Refractory to Oral Diuretics. Have Completed our IND Opening Study Which Demonstrated Similar Bioavailability vs Oral and IV Formulations. Our Product Is Intended to Act as an Outpatient Option for Patients… Presenter: Ben Esque March 21, 2023